StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New documents out on Sedar- Nov 8

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Nov 09, 2021 11:19am

83 Views

Post# 34104926

RE:RE:RE:New documents out on Sedar- Nov 8

Let's make those paid bashers work, lol...

gojotv! wrote:
Basher(s same guy, really) has been working all day to swarm the good news off the front page. So, here's my 3-"like" post for today, in reply to Lithlover...

(Three people agreed. Tells you there's something to it, despite the basher's never-ending shart-stream of lies...)

gojotv! wrote: Oho! You know what this means...!
Care Oncology hit those milestones necessary to claim the 8,000,000 shares!
Already? That was fast!
Hoohoo, no wonder the company's been so quiet... They're busy testing patients and making money!
Financials are going to be exciting! Hold onto your hats!
(From the news release about the acquisition:

"StageZero acquired all of the shares of Clinics Operations Limited by issuing today 12,400,000 StageZero common shares. StageZero is obligated to issue an additional 2,500,000 StageZero common shares, contingent upon Clinic Operations Limited obtaining a Care Quality Commission license in the United Kingdom. A further 8,000,000 common shares are issuable by StageZero contingent upon the achievement of certain milestones and StageZero shareholder approval."

Amazing buying opportunity for the investor with eyes to see and ears to hear, lol. GLTA!

LithLover wrote: Vote on milestone shares and new board member:

STAGEZERO LIFE SCIENCES 70 East Beaver Creek, Suite 30 Richmond Hill, Ontario L4B 3B2 NOTICE OF SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the special meeting of shareholders (the “Meeting”) of STAGEZERO LIFE SCIENCES (the “Corporation”) will be held on Thursday, December 9, 2021, at 2:00 p.m. (Eastern time), via live webcast at https://virtual-meetings.tsxtrust.com/1234 (meeting ID: 1234, case sensitive password: stagezero2021)

for the following purposes:

1. to consider, and if deemed advisable, to approve, with or without variation, an ordinary resolution authorizing and approving the issuance of 8,000,000 common shares of the Corporation to Health Clinics Limited in connection with the prior acquisition of all of the issued and outstanding shares of Clinic Operations Limited, a wholly owned subsidiary of Health Clinics Limited, which would materially affect control of the Corporation (as such term is defined in the TSX Company Manual);

2. to transact such other business that properly comes before the Meeting (or any postponement(s) or adjournment(s) of the Meeting thereof).

Richard Huston, Chairman of Health Clinics Limited, will be appointed to the Board prior to the Meeting date in connection with the Transaction.

The record date for determining holders of common shares (each a “Shareholder”) entitled to receive this notice of special meeting and to vote at the Meeting (or any postponement or adjournment of the Meeting) is the close of business on October 22, 2021.

Particulars of the foregoing matters are set forth in the management information circular of the Corporation (the “Circular”) accompanying this notice (the “Notice of Meeting”) and enclosed form of proxy (the “Proxy”).

This Notice of Meeting and the accompanying Circular have been sent or been made available to each director of the Corporation, each shareholder of the Corporation entitled to notice of the Meeting and the auditors of the Corporation.